Lihi Segal is the CEO and co-founder of revolutionary microbiome-based health app, DayTwo, which uses big data and machine learning algorithms to create personalised nutrition plans. DayTwo is based on research conducted by Professor Eran Segal and Eran Elinav from the Weizmann Institute in Israel, which was used to create an algorithm that can predict a patient’s glucose response to foods based on their personal and microbiome data. The algorithm was shown to accurately predict blood glucose responses in 800 participants whose individual blood glucose was highly variable in response to the same meal. Since 2016, DayTwo has offered their accessible and personalised healthcare services throughout Israel and the United States, delivering evidence-based and personalised healthcare to consumers.